Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
Net Income (Common)
Creo Medical Group PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Creo Medical Group PLC
LSE:CREO
|
Net Income (Common)
-£26.9m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Net Income (Common)
$263m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Net Income (Common)
$17.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Net Income (Common)
-$447.8m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Net Income (Common)
£2.4m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Angle PLC
LSE:AGL
|
Net Income (Common)
-£22.3m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Net Income (Common)?
Net Income (Common)
-26.9m
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Net Income (Common) amounts to -26.9m GBP.
What is Creo Medical Group PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-19%
Over the last year, the Net Income (Common) growth was -10%. The average annual Net Income (Common) growth rates for Creo Medical Group PLC have been -19% over the past three years .